Introduction
The v-mos gene of the Moloney murine sarcoma virus (Mo-MuSV) encodes a serine/threonine protein kinase (van Beveren et al., 1981; Maxwell and Arlinghaus, 1985b) . The v-Mos protein contains the entire 343-amino acid c-Mos sequence plus a 31-amino acid sequence at its amino terminus which results from the fusion of viral env sequences (including the initiation codon) upstream of the c-mos open reading frame (van Beveren et al., 1981) . The c-Mos protein is expressed in germ cells. It plays an important role during meiotic divisions of oocytes (reviewed in Singh and Arlinghaus, 1997) . As an essential component of an activity, cytostatic factor (CSF), c-Mos is responsible for the metaphase II arrest of unfertilized eggs in vertebrates (Sagata et al., 1989) . Loss of Mos function causes reduced fertility in female mice and the development of ovarian teratomas as a result of parthenogenetic activation of oocytes/eggs (Colledge et al., 1994; Hashimoto et al., 1994; Pham et al., 1997) . Ectopic expression of the normal c-mos gene from a foreign promoter causes neoplastic transformation of NIH3T3 cells. The transforming activity of v-mos can be attributed, therefore, to its inappropriate expression in somatic cells. Both v-Mos and c-Mos are able to activate the MAP kinase pathway by directly phosphorylating MAP kinase kinase (Posada et al., 1993; Nebreda et al., 1993; Pham et al., 1995; Chen and Cooper, 1995) . Furthermore, because of their similarity in structure, v-Mos is able to substitute cMos for its function in oocytes (Freeman et al., 1990) .
To understand various aspects of regulation of cMos function, we are investigating the proteins that interact with c-Mos and v-Mos. Although several cMos-interacting proteins have been described (Zhou et al., 1991a (Zhou et al., , 1992 Bai et al., 1992a Bai et al., ,b, 1993 Cooper, 1995, 1997; Chen et al., 1997) , which help to explain the basis of c-Mos function in oocyte maturation and cellular transformation, regulation of c-Mos activity is still poorly understood. In this study we provide evidence that Hsp70 molecular chaperone is a major Mos-associated protein. Our further experiments based on the known biochemical properties of Hsp70 indicated that Hsp70 plays an important functional role in c-Mos regulation. To our knowledge, this is the ®rst report of an association between Hsp70 and a labile serine/threonine protein kinase. We also provide evidence that c-Mos residue Ser-3 which is important for the regulation of c-Mos protein kinase is also important for the Mos-Hsp70 interaction.
Results
A number of cellular proteins coprecipitate with Mos during immunoprecipitation with several antipeptide Mos antibodies. One approach to identify these Mosassociated proteins is through their detection with antibodies against the known proteins. In this study, we succeeded in identifying Hsp70 as one of the Mosassociated proteins by this approach. We began by analysing the cellular proteins that associate with fulllength v-Mos and v-Mos residues 32 ± 374 (which is equivalent to c-Mos). Although v-Mos(32 ± 374) encoded by the Mo-MuSV124 v-mos gene contains 10 amino acid substitutions in the protein kinase domain of mouse c-Mos (van Beveren et al., 1981) , both behave similarly by several criteria that include protein kinase activity, patterns of phosphorylation and associated proteins. Therefore, to take optimal advantage of our antipeptide antibodies, which are based on the v-Mos sequence, and to examine the eect of v-Mos residues 1 ± 31 on the kinase function, we carried out initial analysis using constructs encoding v-Mos(32 ± 374). For the purpose of this study, v-Mos(32 ± 374) will be referred to as Mos to distinguish it from c-Mos and v-Mos.
Coimmunoprecipitation of Mos and Hsp70
v-Mos and Mos were expressed in COS-1 cells by transfection with plasmids in which the cloned fulllength or truncated v-mos gene was expressed from SV40 late promoter. Two days after transfection, cells were metabolically labeled with 35 S-methionine for 30 min and lysed under relatively mild detergent conditions to preserve protein complexes. Immunoprecipitation was carried out with three dierent antipeptide antibodies raised against v-Mos residues 37 ± 55, 260 ± 271, and 363 ± 374 and with a commercially available monoclonal antibody raised against recombinant human Hsp70 (Figure 1 ). The Hsp70 antibody recognizes eciently both Hsp70 and Hsc70 from human and monkey. All three anti-Mos antibodies precipitated v-Mos and Mos eciently; a number of cellular proteins coprecipitated with Mos and v-Mos. One of these proteins, which comigrates with Hsp70, coprecipitated with Mos more eciently than it did with v-Mos (compare Figure 1 lanes 5, 9, and 14 with lanes 3, 8, and 12, respectively). In addition to the Hsp70-sized protein, a number of proteins coprecipitated with Mos, including p60, p35, p30, and p25 (not marked in Figure 1 ). The identity of these proteins remains to be determined.
To ®rst determine whether Mos associates with Hsp70, we analysed anti-Hsp70 immunoprecipitates for the presence of Mos. Both Mos-and v-Mos-sized proteins were present in anti-Hsp70 immunoprecipitates prepared from the cells expressing Mos and v-Mos, respectively (Figure 1, lanes 17 and 18) . In agreement with the results obtained with the anti-Mos immunoprecipitates, Hsp70 association with v-Mos was weaker than with Mos. We conclude that the 31 amino acids present at the amino-terminus of v-Mos, but absent in Mos, destabilize the Mos-Hsp70 association. We also examined the ability of mouse c-Mos to associate with Hsp70 and found that c-Mos and Mos behave similarly (data not shown). Association between Mos and Hsp70 was quite strong as it could survive RIPA buer containing 1% NP ± 40, 1% sodium deoxycholate and 0.1% sodium dodecyl sulfate during radioimmunoprecipitation (data not shown). It is important to note that Mos is a lowabundance protein and therefore cannot be detected by SDS ± PAGE among 35 S-methionine labeled proteins present in cell extract (compare lanes 19 and 20 in Figure 1 ). Despite the low-abundance of Mos, antiHsp70 immunoprecipitates showed Mos as the most prominent band (Figure 1 ). This result indicates that Mos has an unusually high preference for Hsp70 association.
To establish that the Hsp70-sized protein coprecipitated with Mos is Hsp70, we compared its partial V8 protease digestion fragments with those of authentic Hsp70 immunoprecipitated with anti-Hsp70. All the fragments generated from the Mos-associated Hsp70-sized protein were also generated from the authentic Hsp70 ( Figure 2B ). Similarly, V8 protease (lanes 3, 4, 8, 12, 13 and 17) or v-Mos residues 32 ± 374 (indicated as Mos since it is similar to c-Mos; lanes 5, 6, 9, 14, 15, 18 and 20) were transfected into COS-1 cells. Two days later, the proteins were metabolically labeled with 35 S-methionine for 30 min and analysed by immunoprecipitation with three dierent polyclonal anti-Mos peptide antibodies, as indicated, and a monoclonal Hsp70 antibody. The controls included mock-transfected cells (lanes 1, 2, 7, 10, 11, 16 and 19) and immunoprecipitation with the peptideblocked antibodies (peptide+lanes). Lanes: 1 ± 18, immunoprecipitates resolved on 8% gel; 19 and 20, total cell extracts resolved on 12% gel. Shown at right are prestained molecular-weight markers in kilodaltons (Diversi®ed Biotech, Boston, MA, USA). Ab, antibodies digestion fragments generated from the Mos-sized protein coprecipitated with Hsp70 were identical to the fragments generated from authentic Mos immunoprecipitated with anti-Mos (Figure 2A ). These results strongly suggested that Mos associates with Hsp70. More than one homolog of Hsp70 may be expressed in a given cell type (reviewed in Rassow et al., 1997) but, thus far, we have not identi®ed the particular homolog or homologs of Hsp70 that associate with Mos. Some minor V8 protease fragments resulting from the digestion of authentic Hsp70 were either missing or were of lower abundance in Mos-associated Hsp70 (compare Figure 2B lanes 1 and 2 with lanes 5 and 6) . One interpretation of these data is that some but not all homologs of Hsp70 associate with Mos.
It was important to rule out that the Hsp70 antibody does not cross-react with Mos. To do so, we immunoblotted the lysate from c-mos-transfected cells with the Hsp70 antibody ( Figure 3A) . Lack of a cMos-sized band in the Western blot indicates that the Hsp70 antibody does not cross-react with Mos.
The data in Figure 1 indicate that Mos is not a major protein in the lysate of transfected COS-1 cells. To quantitate the Mos protein further, we immunoblotted the total cell lysates from Mos-and c-Mostransfected COS-1 cells along with the lysate from MuSV124-infected NIH3T3 cells ( Figure 3B ). The amount of c-Mos, Mos and v-Mos in these extracts was comparable to each other. Each amounted to about 0.004% of total cellular protein as quantitated using the known amounts of GST-v-Mos in Western blots (data not shown). Our estimate is in agreement with the estimate of v-Mos in MuSV infected NIH3T3 cells by Papko et al. (1982) . Intracellular concentration of v-Mos in MuSV-infected NIH3T3 cells is comparable to c-Mos concentration in unfertilized Xenopus eggs (Sagata et al., 1989) .
To provide further evidence for Mos-Hsp70 association, we carried out immunoprecipitation-Western immunoblotting (IP-Western) analysis. Hsp70 coprecipitated with c-Mos in anti-Mos precipitates was speci®cally detected by anti-Hsp70 in Western blot ( Figure 4A ). Conversely, c-Mos coprecipitated with Hsp70 in anti-Hsp70 immunoprecipitate was detected by anti-Mos in the Western blot ( Figure 4B ). Appropriate controls included in these experiments (mock-transfected cells and immunoprecipitates with peptide-blocked anti-Mos antibodies) ruled out the possibility of these results being merely due to antibody cross-reactivities (Figure 4) . In this experiment, the plasmid construct expressing mouse c-Mos was used for transfection. c-Mos is recognized poorly by the anti-v-Mos(363 ± 374) antibodies used here because of an amino acid dierence in the peptide antigen. Still, the data provided clear evidence of a speci®c association between c-Mos and Hsp70.
To determine that c-Mos interacts with Hsp70 in physiological conditions, we performed IP-Western analysis on lysate prepared from Xenopus eggs. According to these data, Hsp70 coimmunoprecipitated with c-Mos xe ( Figure 5C ). Based on Western blotting analysis, both c-Mos xe and Hsp70 antibodies specifically recognized their respective antigens ( Figure  5A ,B). It is important to note that the Mos xe antibody S-methionine-labeled Mos-sized protein that coimmunoprecipitated with Hsp70 (A, lanes 3 and 4), and the Hsp70-sized protein that coimmunoprecipitated with Mos (B, lanes 1 and 2) were subjected to partial V8 digestion along with the authentic Mos (A, lanes 1 and 2) and Hsp70 (B, lanes 3 and 4). The digested protein fragments were analysed by SDS ± PAGE on a 15% gel. Lanes 5 and 6 in (B) show a shorter exposure of lanes 3 and 4. The source of each protein band subjected to V8 digestion is indicated at the bottom of the lanes; Mos and Hsp70 indicate anti-Mos and anti-Hsp70 immunoprecipitates, respectively 
Hsp70-Mos complexes can phosphorylate MEK1
Hsp70 homologs play an important role as molecular chaperones in the folding of numerous proteins (Hartl, 1996; Rassow et al., 1997) . One of these roles is to assist the folding of nascent polypeptide chains (Bukau et al., 1996) . Therefore, in evaluating the signi®cance of our results, the key question to address was whether Hsp70-associated Mos represented only improperly folded newly synthesized Mos molecules. To address this question, we determined the protein kinase activity of Mos associated with Hsp70. The v-Mos, Mos, and a kinase-inactive K90R mutant of Mos were either immunoprecipitated with anti-v-Mos(37 ± 55) or coprecipitated with Hsp70 in anti-Hsp70 immunoprecipitates. Mos protein kinase activity was determined using GST-MEK1 (K97R kinase-inactive mutant) as a substrate ( Figure 6 ). Results from this experiment clearly showed that Mos coprecipitated with Hsp70 has protein kinase activity. Based upon a parallel experiment involving metabolic labeling with 35 Smethionine, the amount of Mos protein present in anti-Hsp70 immunoprecipitate was one-third of that present in anti-Mos immunoprecipitate. The speci®c activity of Mos protein kinase in anti-Hsp70 immunoprecipitate was comparable, therefore, to the speci®c activity of Mos protein kinase in anti-Mos immunoprecipitates (compare Figure 6 lanes 5 and 9). Since the protein kinase catalytic domain of Mos (residues 67 ± 343) encompasses 80% of Mos sequence, this result indicates that the Hsp70-associated Mos protein is not grossly denatured. We noted that Mos present in antiHsp70 immunoprecipitates autophosphorylated extremely poorly, which may be the result of masking of autophosphorylation sites by Hsp70 association. Signi®cance of Mos autophosphorylation is not known at present but based on our phosphopeptide mapping data most of the in vitro phosphorylation that occurs on Mos in anti-v-Mos(37 ± 55) immunoprecipitates does not occur on Mos in transfected COS-1 cells 
Role of Mos-Hsp70 interaction
Among several domains present in Hsp70, the ATPase domain and the peptide-binding domain are present in all its homologs. Structural change in either of these two domains by ATP or peptide binding causes a change in the other one. Thus, ATP binding causes the release of the bound peptide, which in turn stimulates the ATPase activity of Hsp70. The ADP-bound form of Hsp70 has increased anity for peptide binding. The proper folding of an Hsp70-associated protein requires cycles of association and dissociation. Therefore, ATP is required for Hsp70 to function as a molecular chaperone. Laboratories working on c-Mos have known that c-Mos protein kinase activity is very labile in cell extracts. In light of our results, we postulated that ATP would be required to maintain association/dissociation cycles of c-Mos-Hsp70 complexes and, therefore, the c-Mos protein kinase activity.
The following experiments were carried out to investigate this possibility.
The ®rst important experiment was to determine whether addition of ATP to cell extracts from mostransfected cells would prevent the loss of Mos protein kinase activity. Mos protein kinase activity was almost totally lost upon incubation of the cell extract on ice for 4 h ( Figure 7A ). In this experiment, Mos kinase activity was followed by observing transphosphorylation of GST-MEK1(K97R) as well as the cellular protein p60. p60 appears to be a true substrate of Mos as it was not phosphorylated by the immunoprecipitates containing kinase-inactive Mos ( Figure 7A , lane 1), although the degree of p60 phosphorylation varied signi®cantly among experiments. Of interest, addition of ATP (3 mM) and MgCl 2 (5 mM) to the cell extract had a signi®cant protective eect as only 50% activity was lost under these conditions (compare Figure 7a , lanes 3 and 9). ATP alone without MgCl 2 had no protective eect (not shown). MgCl 2 alone had a slight protective eect. Testing the eect of ATP in the concentration range of 1 mM ± 3 mM, we found that 2 ± 3 mM ATP provided optimal protection against the loss of Mos activity (data not shown). To determine whether protein phosphorylation-dephosphorylation contributed to the protection of Mos kinase activity in our system, we tested the eect of sodium¯uoride (NaF), a phosphatase inhibitor. In our system, NaF had a modest additional protective eect when added along with ATP and MgCl 2 (compare Figure 7A lanes  9 and 11) . NaF had a less signi®cant eect possibly because our extraction buer already contained another phosphatase inhibitor, sodium pyrophosphate, which causes a dramatic improvement in the activity of Mos protein kinase (Maxwell and Arlinghaus, 1985a) . The eect of pyrophosphate was ®rst discovered while attempting to improve the assay for vMos protein kinase activity (Maxwell and Arlinghaus, 1985a) .
Next, we investigated that the hydrolysis of ATP was required for its protective eect on Mos kinase in cell extracts. In this experiment the cell lysate from cMos-transfected COS-1 cells was incubated at room temperature for 4 h which was followed by c-Mos immune complex autokinase assay. We found that the loss of c-Mos kinase activity was prevented by ATP or thio-ATP ( Figure 7B ). There was no signi®cant Figure 7 Protection by ATP against the loss of Mos protein kinase activity in cell lysates. (A) Cell lysates from mos-transfected COS-1 cells were incubated at 48C for 4 h without any addition (lanes 5 and 6); or with 5 mM MgCl 2 (lanes 7 and 8); 5 mM MgCl 2 and 3 mM ATP (lanes 9 and 10); or with 5 mM MgCl 2 3 mM ATP and 10 mM NaF (lanes 11 and 12). Then Mos was immunoprecipitated with anti-v-Mos(37 ± 55) and subjected to protein kinase assay in the presence of GST-MEK1 (K97R) as in Figure 6 . As negative and positive controls, cell extracts containing kinase-inactive K90R Mos (lanes 1 and 2) or Mos (lanes 3 and 4) were used immediately after preparation in the usual manner. In addition to autophosphorylation and transphosphorylation of MEK1, phosphorylation of a 60-kDa protein (p60) by Mos can also be seen. (B) Cell lysate from c-mostransfected COS-1 cells was incubated at room temperature for 4 h in the presence of 5 mM MgCl 2 (lanes 3 and 4), 10 mM sodium molybdate (lanes 5 and 6), 5 mM MgCl 2 plus 3 mM ATP (lanes 9 and 10), 5 mM MgCl 2 plus 1 mM thio-ATP (lanes 11 and 12) or without any addition (lanes 13 and 4). These lysates along with the control lysate without any prior incubation (lanes 1 and 2) were subjected to immune complex autokinase assay. The 32 Plabeled c-Mos band is indicated as Mos. The lanes marked as peptide+represent kinase assays with control immunoprecipitates that were obtained with the peptide-blocked antibody protection by a non-hydrolysable analog of ATP, AMPPNP. Similarly, Mg 2+ alone and a transition metal molybdate were without any eect. We conclude that the hydrolysis of ATP is important for its protective eect.
To determine whether the loss of Mos kinase activity in the absence of ATP is caused by enhanced degradation of Mos, we examined the fate of Mos and Hsp70 metabolically labeled with 35 S-methionine after incubation of the cell extracts with and without ATP. When Mos-associated Hsp70 were immunoprecipitated with anti-v-Mos(363 ± 374) and analysed by SDS ± PAGE, we observed that the amount of Mos and associated Hsp70 remained essentially unchanged upon incubation on ice for 4 h with or without ATP (Figure 8) . Furthermore, we observed that the loss of Mos kinase activity in COS-1 cell extracts was reversible in the early stage but not after 24 ± 48 h incubation (data not shown). Based upon what is known about the Hsp70 chaperoning mechanism (Hartl, 1996; Bukau et al., 1996; Rassow et al., 1997) , we suggest that ATP may be needed to keep Mos in an active conformation which depends on cycles of association and dissociation with Hsp70. In the absence of ATP, the Mos-Hsp70 complex may be unable to dissociate and eventually Mos becomes totally inactive upon prolonged incubation. Although a lack of exogenously added ATP did not enhance Mos degradation in cell extracts, experiments reported below utilizing COS-1 cells transfected with mutant versions of Mos are consistent with a role of Hsp70 interaction in the regulation of Mos turnover and Mos protein kinase activity in vivo.
Eect of the S3A mutation on Mos-Hsp70 interaction
Considering the well known function of Hsp70 as a molecular chaperone, Mos-Hsp70 interaction may be important for mediating Mos interaction with other cellular proteins including its regulators and/or targets. To understand the functional signi®cance of MosHsp70 interaction, one can try to create mutations in Mos which speci®cally abolish its interaction with Hsp70. Alternatively, one can utilize the mutations that are known to cause speci®c defects in c-Mos function and regulation. Here we describe the results obtained with the later strategy. First, we decided to focus on the c-Mos mutations involving phosphorylation sites because there are indications that a number of protein ± protein interactions with c-Mos may be mediated by phosphorylation. Of particular importance is the c-Mos residue Ser-3 which is phosphorylated in oocytes after GVBD (Freeman et al., 1992; Nishizawa et al., 1992) . Phosphorylation at Ser-3 is believed to be important for the stability and protein kinase activity of c-Mos. The c-Mos residue Pro-2 is important for the proteolysis of c-Mos by the ubiquitin-proteosome system (Nishizawa et al., 1993) . Phosphorylation at the adjacent residue, Ser-3, may interfere with the recognition of Pro-2 by the ubiquitin system (Nishizawa et al., 1992) . Consistent with this model, the substitution of Ser-3 with Ala and Glu results in unstable and stable c-Mos, respectively. In addition, the S3A but not the S3E mutation inhibits the interaction of c-Mos catalytic domain with its substrate MEK1 (Chen and Cooper, 1995) . The role of Ser-3 phosphorylation in regulating c-Mos is not completely understood. A direct correlation between Ser-3 phosphorylation and c-Mos stability on its protein kinase activity has not been shown. The use of the S3A mutant has also given contradictory results as, in contrast to the results obtained by Nishizawa et al. (1992) and Chen and Cooper (1995) , Freeman et al. (1992) did not observe any eect of the S3A mutation on c-Mos function. Currently, it is not known whether Ser-3 and phosphorylated Ser-3 mediate Mos interaction with the proteins involved in Mos regulation.
To determine whether interaction with Hsp70 molecular chaperone may be involved in the regulation of turnover and protein kinase activity of c-Mos, we examined the eects of the S3A and S3E mutations on Mos interaction with Hsp70. As expected from the results with the analogous Xenopus c-Mos mutants expressed in Xenopus oocytes or in somatic cells (Nishizawa et al., 1992; Chen and Cooper, 1995) , the S3A but not the S3E mutation inhibits v-Mos protein kinase and accelerates the degradation of Mos produced in transfected COS-1 cells (Yang et al., 1998) . We immunoprecipitated 35 S-methionine-labeled mutant Mos with anti-v-Mos(363 ± 374) to ®nd that the S3A but not the S3E mutation almost completely abrogated the co-precipitation of Hsp70 with Mos ( Figure 9 , compare lanes 1 of all three panels). The loss of Hsp70 coprecipitation with Mos occurred only in Figure  7a . Then, the Mos protein was immunoprecipitated with anti-vMos(363 ± 374) and analysed by SDS ± PAGE followed bȳ uorography. Incubation conditions: 0 h (lanes 1, 2); 4 h (lanes 3, 4); 4 h with 5 mM MgCl 2 (lanes 5, 6); 4 h with 5 mM MgCl 2 and 3 mM ATP (lanes 7, 8) case of the S3A mutant; all other phosphorylation site mutants (which included S16A, S16E and S25A) behaved similar to the wild-type (WT) Mos in this regard (data not shown). The S16A mutation speci®cally abrogates the coprecipitation of a cellular protein p35 with Mos (CD Pham, VB Vuyyuru, Y Yang, W Bai and B Singh manuscript submitted for publication).
Although Hsp70 did not coprecipitate with the S3A mutant Mos immunoprecipitated with anti-Mos antibodies, the S3A mutant Mos coprecipitated eciently with Hsp70 immunoprecipitated with the anti-Hsp70 antibody. One possible explanation of this surprising result may be that although the S3A mutation signi®cantly weakens Mos-Hsp70 interaction, the binding of Hsp70 antibody to Hsp70 somehow stabilizes these weak Mos-Hsp70 complexes. The Hsp70 antibody was raised using whole recombinant human Hsp70 but the exact epitope that is recognized by this monoclonal antibody is not known. We tried to use some other commercially available Hsp70 and Hsc70 antibodies (K-20 and K-19, Santa Cruz Biotechnology) to resolve this issue (H Liu, VB Vuyyuru, CD Pham, and B Singh unpublished observations). These antibodies immunoprecipitated Hsp70 and Hsc70, respectively, but failed to coprecipitate Mos possibly because they interfere with the chaperoning function of Hsp70.
At this point, we chose to utilize a well characterized Hsp70 monoclonal antibody, clone BB70, which has been used previously to investigate Hsp70-associated proteins (Uzawa et al., 1995) . First we found by Western blotting that the antibody recognizes Hsp70 in COS-1 cells with high speci®city and that it does not cross-react with c-Mos ( Figure 10A ). Upon immunoprecipitation of 35 S-methionine-labeled proteins, we found that c-Mos coimmunoprecipitated with Hsp70 eciently ( Figure 10B ). The S3A mutation caused a dramatic inhibition in the association of c-Mos with Hsp70. In this experiment the relative amount of cMos proteins was determined by immunoprecipitation with anti-v-Mos(37 ± 55) ( Figure 10C ). The amount of the S3A c-Mos was about 50% of WT c-Mos presumably due to increased proteolysis of the mutant c-Mos. These results indicate that the c-Mos residue Ser-3 is important for Hsp70 interaction. Phosphoryla- Figure 9 Eects of mutating Ser-3 on Mos binding with Hsp70. The wild-type Mos and its mutants S3A and S3E were produced by transfection in COS-1 cells. The proteins were labeled with 35 Smethionine and immunoprecipitated as in Figure 1 . Antibodies used for immunoprecipitation, indicated at the bottom, were antiv-Mos(363 ± 374) (peptide7lanes), peptide-blocked anti-vMos(363 ± 374) (peptide+lanes) and anti-Hsp70 W27 clone. The amount of the S3A mutant Mos was lower than WT Mos, therefore, the ®lm in the middle panel was exposed for a longer time. Exposure times: left and right panels, 1d; middle panel, 2d tion of Ser-3 may lead to a modi®ed c-Mos interaction with Hsp70 and thus alter its fate with regards to proteolysis and kinase regulation.
Discussion
In this paper, we demonstrate that Mos associates with the Hsp70 molecular chaperone. This association is analogous to the association between another molecular chaperone, Hsp90 and some labile protein kinases including Src, Raf, Cdk4 and Wee1 (Stancato et al., 1993; Xu and Lindquist, 1993; Aligue et al., 1994; Schulte et al., 1995; Stepanova et al., 1996) . A good amount of Mos protein observed in anti-Hsp70 immunoprecipitate (Figure 1 ) argues for a speci®c and high-anity interaction between Mos and Hsp70. Absolute amount of Mos in cells is very low, and SDS ± PAGE analysis of total cell lysate from 35 Smethionine-labeled mos-transfected cells did not reveal a Mos band when compared to a lysate from mock-transfected cells (Figure 1 ). In contrast, Mos protein was observed as the most prominent band in anti-Hsp70 immunoprecipitate. While the stoichiometry of Mos-Hsp70 interaction remains to be determined, data such as in Figure 1 indicates that most of Mos is involved. To our knowledge, Mos is the ®rst labile protein kinase found to associate with Hsp70 to such a great extent. In addition to the high degree of this protein-protein interaction, what makes it interesting is the correlation between the Hsp70 association and Mos regulation, both processes being regulated by the known potentially important phosphorylation site Ser-3 of c-Mos. Hsp70 is generally viewed as a molecular chaperone which interacts with an unfolded or improperly folded protein initially only to transfer the protein later to other molecular chaperones, e.g., Hsp90. We did not observe any signi®cant amount of Hsp90 in protein complexes containing Mos. We believe that like Hsp90 in the regulation of Src, Raf, Cdk4 and Wee1 protein kinases (Stancato et al., 1993; Xu and Lindquist, 1993; Aligue et al., 1994; Schulte et al., 1995; Stepanova et al., 1996) , Hsp70 is important in the regulation of cMos function. One possibility is that Mos is intrinsically unstable and it needs to stay associated with Hsp70 chaperone in order to be protected from proteolysis. Such a model involving continued interaction between a protein and a molecular chaperone would not be unique for Mos; a similar situation may exist in case of several proteins and molecular chaperones (reviewed in Pennisi, 1996) .
Previously, gel ®ltration experiments from our laboratory showed that c-Mos ectopically expressed in somatic cells fractionates predominantly as a 500 kDa complex (Bai et al., 1992b) . In general, Hsp70 is able to interact with other molecular chaperones, and thus it fractionates as a large multiprotein complex (reviewed in Pennisi, 1996 and Frydman and HoÈ hfeld, 1997) . This property of Hsp70 and ATP requirement for its function would be consistent with the large size of c-Mos-containing protein complexes and the high amount of ATP required to preserve c-Mos protein kinase activity. However, it is also possible that Hsp70 associates with c-Mos in the early stages of multiprotein complex assembly and is absent from the ®nal c-Mos-containing protein complex. In addition to Hsp70, a number of proteins (p60, p35, p30 and p25) were found present in protein complexes containing Mos. Whether any of these proteins are additional molecular chaperones remains to be seen. Interestingly, the p60 protein also associates with Hsp70 ( Figure 1 and data not shown). In all our experiments, thus far, p60 coprecipitation with Mos parallels Hsp70 coprecipitation; we have been unable to dissociate one without dissociating the other from Mos. As a separate point, since some other molecular chaperones in addition to Hsp70 also require ATP for their function, we cannot conclude that the requirement of ATP (in mM range) for the protection of Mos activity is due to Hsp70 only. Furthermore, ATP may play multiple additional roles in cell extracts; it is possible that ATP could directly or indirectly (e.g., by aecting molecular chaperones) in¯uence the phosphorylation state of Mos and/or other proteins. Although 3 mM ATP protects the loss of CSF activity in egg extracts Masui, 1988, 1989) , the precise role(s) of ATP in this system is not known.
Our results showing that the S3A mutation aects Mos-Hsp70 interaction is signi®cant considering that the S3A mutation in Xenopus c-Mos inhibits the interaction between the c-Mos catalytic domain and its substrate MEK1 (Chen and Cooper, 1995) . The S3A mutation also inhibits the kinase activity of v-Mos (Yang et al., 1998) . At this time, our results indicate a correlation between in vitro Hsp70 interaction and kinase activity of Mos. Further studies are needed to appreciate the full scope of Mos-Hsp70 interaction. Our approach is to identify various Mos-interacting proteins so that the biochemical role of a given protein ± protein interaction, e.g. Mos-Hsp70, can be better understood in relation to other Mos-interacting proteins. At present we also do not know how the S3A mutation aects Mos interaction with Hsp70. Is Ser-3 a part of Hsp70 interaction motif or more likely Ser-3 mediates other protein ± protein interactions with cMos which in turn in¯uence Hsp70 association with cMos? Future studies will provide answers to this and other questions regarding the role of Hsp70 in the regulation of c-Mos function. These future studies will also explain whether pleotropic eects of the Ser-3 phosphorylation on Mos protein kinase and Mos turnover are due to Hsp70 association.
We observed that the Hsp70 interaction was weaker with v-Mos than with Mos. This observation would be consistent with the possibility suggested by our data obtained with the Ser-3 mutants (Figures 9 and 10 ) that the amino-terminus of Mos (or c-Mos) is important for mediating Hsp70 interaction. Another evidence for the involvement of amino-terminal sequence of Mos in Hsp70 interaction comes from the less and weaker association of Hsp70 observed in anti-Mos(6-24) immunoprecipitates than in antiMos(332 ± 343) immunoprecipitates; strength of protein ± protein interaction was determined by high-salt and detergent washes (H Liu, VB Vuyyuru, CD Pham and B Singh, unpublished observations). Our interpretation of these data is that the antibody binding near the amino-terminus, analogous to the eect of the amino acid sequence extension in v-Mos, weakens Hsp70 interaction. The catalytic domain of Mos may not be involved signi®cantly in Hsp70 interaction since Hsp70-bound Mos is active as a protein kinase ( Figure  6 ). c-Mos (or Mos) behaves dierently from v-Mos in several ways: c-Mos is incorporated into larger macromolecular complexes more eciently than vMos (Bai et al., 1992b) ; c-Mos associates with microtubules better than v-Mos (Zhou et al., 1991b; Bai et al., 1992) ; and c-Mos is localized into the nucleus more eciently than v-Mos (Zhou et al., 1991b) . Whether any or all of these properties of cMos are due to stronger interaction with and proper chaperoning by Hsp70 remains to be seen.
There are several Hsp70 homologs, and some are expressed in a tissue-speci®c manner. In future studies, determining which Hsp70 homolog or homologs associate with c-Mos in germ cells will be important. We view the c-Mos-Hsp70 interaction as resulting from a specialized function of Hsp70 that may be similar to the unique function of Hsp70 ± 2 in male germ cells (Dix et al., 1996) . In addition to ®ve Hsp70s common to germ cells and somatic cells of mammals, spermatogenic cells synthesize Hsp70 ± 2 during meiosis. In Hsp70 ± 2 7/7 mice that are otherwise normal, the only defect is in the meiotic divisions of male germ cells (Dix et al., 1996) . Mutagenesis studies currently in progress in our laboratory are directed at understanding further the molecular basis and biochemical role of Mos-Hsp70 interaction. We believe that the identi®cation of Hsp70 as a Mos-interacting protein will prove to be important in unraveling the regulation of c-Mos function in eggs. Mos localizes to centromere (Wang et al., 1994) but the molecular basis of this localization is not yet known. It is conceivable that Mos-Hsp70 association plays a role in the assembly and subcellular localization of Mos to centromere. In this regard, it is interesting that a centromere protein, centrin, also associates with heat shock proteins, including Hsp70 in CSF-arrested Xenopus oocytes (Uzawa et al., 1995) .
Materials and methods

Plasmids
Full-length v-mos gene of Mo-MuSV124 and the deletion mutant that would encode Mos, both cloned in the expression vector pJC119 (Hannink and Donoghue, 1985; Singh et al., 1986) , were kindly provided by Daniel J Donoghue (University of California, San Diego, CA, USA) as was the kinase-inactive mutant of v-Mos (K121R) (Hannink and Donoghue, 1985) . The amino-terminal deletion mutant of the K121R v-Mos was generated by polymerase chain reaction (PCR). Similarly, mouse c-mos was ampli®ed by PCR using pMS1 (Blair et al., 1981) plasmid DNA as a template and cloned into the XhoI site of pJC119. The sense and antisense primers were designed also to introduce the XhoI site for cloning. The mutations of the Ser-3 residue of Mos were generated by introducing the S3A and S3E mutations in the PCR primer. The DNA sequence was con®rmed by sequencing the cloned gene.
Protein analysis
The plasmids were transfected into COS-1 cells by the DEAE-dextran method as described (Sambrook et al., 1989) . Two days later, the cells were either labeled with 35 Smethionine for 30 min or lysed for carrying out the Mos protein kinase assay or Western immunoblotting as described previously (Pham et al., 1995; Yang et al., 1996) . In all experiments, cell lysis was carried out by douncing or freezing (at 7808C) and thawing once in a buer containing 1% NP-40 (Singh et al., 1988) . Immunoprecipitation was carried out with various v-Mos antipeptide antibodies (Singh et al., 1990) or Hsp70 antibodies (W27 clone from Santa Cruz Biotechnology, Santa Cruz, CA, USA and BB70 clone from Dr David Toft, Mayo Clinic Foundation, Rochester, MN, USA). Unfertilized Xenopus laevis eggs frozen on dry ice were obtained from NASCO (Fort Atkinson, WI, USA). For coimmunoprecipitation analysis, the eggs were lysed by douncing in the same buer as COS-1 cells. c-Mos xe was immunoprecipitated with the C237 antipeptide antibody produced in rabbit (Santa Cruz Biotechnology). Immunoprecipitates were washed extensively in a buer containing 0.1% NP-40 (Singh et al., 1988) .
The V8 protease partial digestion analysis of the 35 Smethionine-labeled Mos and Hsp70 was carried out by the standard procedure as described previously (Maxwell and Arlinghaus, 1985b) . The kinase assay using anti-v-Mos(37 ± 55) or anti-Hsp70 immunoprecipitates and GST-MEK1(K97R) as a Mos kinase substrate was done as described previously (Yang et al., 1996) . Quantitation of relative signal in protein bands in various experiments was performed by densitometry of the bands on X-ray ®lm and/or liquid scintillation counting of the excised gel slices.
